<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T11:35:46+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>中国first in class新药研发，还缺什么？</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/c-daa2n3vGJa18rt8yIE_w</id>
    <link href="https://mp.weixin.qq.com/s/c-daa2n3vGJa18rt8yIE_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来中国副总裁钱江：以学术为导向，深入挖掘市场尚未被满足的临床需求</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/YXTvVh16-K2-fTn2F9Yu4w</id>
    <link href="https://mp.weixin.qq.com/s/YXTvVh16-K2-fTn2F9Yu4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药囊获第9项FDA孤儿药资格认定，创中国药企之最</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/phvR6c8dWpfLkw6q91r2og</id>
    <link href="https://mp.weixin.qq.com/s/phvR6c8dWpfLkw6q91r2og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进KRAS抑制剂sotorasib的专利保护策略</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/pq92yYetn9vl7RyvJ9ZKnQ</id>
    <link href="https://mp.weixin.qq.com/s/pq92yYetn9vl7RyvJ9ZKnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一图读懂 | 2020年NCCN肺癌指南历版更新要点</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/ceBMky86ztMov-s6VCVQug</id>
    <link href="https://mp.weixin.qq.com/s/ceBMky86ztMov-s6VCVQug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在韩国提交Selinexor新药上市申请，用于治疗复发难治性多发性骨髓瘤及弥漫性大B细胞淋巴瘤</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/XQZCY85jhKjpZ7FxI5jdcg</id>
    <link href="https://mp.weixin.qq.com/s/XQZCY85jhKjpZ7FxI5jdcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国创新药license in/out交易TOP15</title>
    <updated>2021-01-03T11:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/1fJKEh1hPsswbu8GaXfvWA</id>
    <link href="https://mp.weixin.qq.com/s/1fJKEh1hPsswbu8GaXfvWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>港股Biotech公司这一年</title>
    <updated>2021-01-02T09:16:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/TJ20vTPoilqJIXF4gEdG_Q</id>
    <link href="https://mp.weixin.qq.com/s/TJ20vTPoilqJIXF4gEdG_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：2020年NMPA批准的新药</title>
    <updated>2021-01-01T08:57:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/ZttCvEXnSLpzmPUEYXB-uA</id>
    <link href="https://mp.weixin.qq.com/s/ZttCvEXnSLpzmPUEYXB-uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>达伯舒（信迪利单抗）患者救助项目启动！3.98万元封顶且门槛价低，患者可及性更高</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/UJVhi-fRhMn-f8-1_iXsfQ</id>
    <link href="https://mp.weixin.qq.com/s/UJVhi-fRhMn-f8-1_iXsfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晚期NSCLC抗血管生成药物治疗中国专家共识：2020 vs 2019对比</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/LkMjYVG_NzuayCHppNU4pQ</id>
    <link href="https://mp.weixin.qq.com/s/LkMjYVG_NzuayCHppNU4pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药「索凡替尼胶囊」获批上市</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/KzbEmAIDBEEwekb9h-B1VQ</id>
    <link href="https://mp.weixin.qq.com/s/KzbEmAIDBEEwekb9h-B1VQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年，这10家创新药公司有望在科创板上市</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/9v0742GtzD-e91ZlzvvCOg</id>
    <link href="https://mp.weixin.qq.com/s/9v0742GtzD-e91ZlzvvCOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science：解决耐药难题，这款来自海洋的抗真菌药有何奇效？</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/kKYyfhPtjgoFIADWghgBVA</id>
    <link href="https://mp.weixin.qq.com/s/kKYyfhPtjgoFIADWghgBVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物战略升级</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/6MQ9WrqR1-RKtzThZ0wd3Q</id>
    <link href="https://mp.weixin.qq.com/s/6MQ9WrqR1-RKtzThZ0wd3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王进：我曾把临床试验带到了战火纷飞的格鲁吉亚</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/5HrNyCAiyHSKKl_2Vx2k0Q</id>
    <link href="https://mp.weixin.qq.com/s/5HrNyCAiyHSKKl_2Vx2k0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维迪西妥单抗获CDE突破性治疗认可，有望填补HER2阳性尿路上皮癌治疗空白</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/kFNAFnzeS-iP7_KG9N066A</id>
    <link href="https://mp.weixin.qq.com/s/kFNAFnzeS-iP7_KG9N066A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature里程碑：双管齐下的抗生素——IspH抑制剂</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/W9BGPwZE5DH5UGn7JiBNsQ</id>
    <link href="https://mp.weixin.qq.com/s/W9BGPwZE5DH5UGn7JiBNsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吉利德科学再交完美答卷，“抗病毒传奇”只为“治愈”而生</title>
    <updated>2020-12-28T07:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/MpoU2VaWXjrfgVNNwbsPQQ</id>
    <link href="https://mp.weixin.qq.com/s/MpoU2VaWXjrfgVNNwbsPQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌靶点XPO1「图鉴」</title>
    <updated>2020-12-28T07:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/DWmuJfzDEFOSb7DeToELbQ</id>
    <link href="https://mp.weixin.qq.com/s/DWmuJfzDEFOSb7DeToELbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>